Abbott is excited to be at HLTH this year, where we’ll outline our vision for the future of healthcare, one that empowers people to optimize their care from the hospital and the doctor’s office to their home – and every step in between. We’ll also shine a light on some of our newest technologies that help people do just that.
Here is an overview of where Abbott will be leading the conversation at HLTH.
Abbott on the Main Stage
Abbott Chairman and CEO Robert Ford will deliver a presentation on HLTH’s Main Stage. Titled “Putting Health in Your Hands,” Mr. Ford’s keynote will delve into how healthcare and connected technologies, such as biowearables, are converging in ways that offer people personalized insights into what their bodies are saying and put them in greater control of their health. The result: a healthcare system that is more responsive, more connected and more tailored to each person’s needs – and uses language we can all understand.
Details: Tuesday, Oct. 10, 9:20 a.m., HLTH Main Stage
Managing the Cost of Diabetes Care
Diabetes is one of the most expensive chronic conditions to manage. According to the American Diabetes Association (ADA), medical expenditures for people with diabetes is $16,752 a year, or 2.3 times more than for people without diabetes.1
The panel discussion “The Diabetes Money Pit” will explore how to reduce costs for diabetes care, from diagnosis and treatment to prevention. Jared Watkin, senior vice president, Diabetes Care, will be among the panelists and highlight how Abbott’s FreeStyle Libre continuous glucose monitoring technology helps people with diabetes improve their glucose control and reduces diabetes-related costs for patients and health systems2, all while costing substantially less than other CGMs.
Details: Sunday, Oct. 8, 2 p.m., Moon Stage
A Firsthand Account of Making a Medical Marvel
There are heart-to-heart conversations, and then there are conversations between two chambers of the heart.
AVEIR DR, the world’s first FDA-approved dual chamber leadless pacemaker, featuring groundbreaking technology that uses the blood’s naturally conductive characteristics to relay messages between each pacemaker. In other words, the two devices use a person’s own body to wirelessly “talk” to each other and synchronize pacing in two chambers of the heart. Smaller, shorter and thinner than a triple A battery, AVEIR DR is a leap forward so revolutionary that one cardiac specialist called its approval “an ‘invention-of-the-internet’-type of moment.”
Vish Charan, divisional vice president, product development for Abbott’s Cardiac Rhythm Management business, led the team that developed AVEIR DR. During his Tech Talk, Charan will tell the story of how nearly a decade of research, development, and innovation resulted in this first-of-its-kind medical device that is just one of the recent additions to Abbott’s broad cardiovascular care portfolio.
Details: Tuesday, Oct. 10, 3:30 p.m., Tech Talk Stage
Food as Medicine
Mary Pittman, DrPH, president and CEO of the Public Health Institute, will moderate “Nourishing Our Nation,” a panel discussion on the many ways that food impacts health. While the logical connection between a good diet and good health seems simple, the reality is often more complicated due to access, social determinants, and other factors.
Pittman is an advisor to Abbott’s Center for Malnutrition Solutions, which the company started in 2021. The Abbott Center for Malnutrition Solutions applies Abbott’s science and expertise in collaboration with others to tackle malnutrition around the world. The work of the Center also contributes to Abbott’s 2030 Sustainability Plan ambition to transform care for malnutrition, chronic disease and infectious disease with a goal to improve the lives of more than 3 billion people by decade’s end.
Details: Sunday, Oct. 8, 3:40 p.m., Earth Stage
References
1 People with diagnosed diabetes incur average medical expenditures of $16,752 per year, of which about $9,601 is attributed to diabetes. On average, people with diagnosed diabetes have medical expenditures approximately 2.3 times higher than what expenditures would be in the absence of diabetes. The Cost of Diabetes | ADA
2 Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World - PMC (nih.gov)
FOLLOW ABBOTT